Home | Policy | Portfolio | Profiles | Pipeline| Products |Heber Biotec | Patents| News |Search |

Download PDF file Business Portfolio 2009

Project Business Portfolio 2009

Biomedical projects

1. Development of a nasal formulation based on the recombinant hepatitis B surface and core antigens (NASVAC) in chronic hepatitis B patients under antiviral therapy.

2. Development of therapeutic vaccine against Hepatitis C virus.

3. Development of a recombinant vaccine against Dengue virus.

4. Molecules with antiviral activity against Dengue virus.

5. Therapeutic Targeting of Colorectal and other Carcinoembryonic Antigen (CEA) Positive Cancers with a Recombinant Divalent Antibody Fragment (CIGB-M3).

6. Development of therapeutic vaccine against Human Papillomavirus 16.

7. Development of a therapeutic vaccine against prostate cancer.

8. CIGB-370. A novel protein compound with antitumor effect.

9. CIGB-166. Anti-VEGF therapeutic recombinant antibodies.

10. CIGB-247. A recombinant antigen for therapeutic vaccine preparations targeting cancer angiogenesis.

11. CIGB-552. Novel peptide with anti-tumor effect useful for cancer treatment.

12. Heberprot-P: A product to enhance diabetic ulcers healing and reduce amputation rate.

13. Use of CIGB-500 as a wide spectrum cyto-protective agent.

14. Altered Peptide Ligand (APL) for treatment of Rheumatoid Arthritis and other Autoimmune Diseases.

15. Use of CIGB-845 as a neuro-protective agent.

Agriculture projects

16. Use of a growth stimulator, Acuabio 1, in aquatic species for aquaculture improvements.

17. Increase of productivity in aquaculture by using non-hormone treated all males’ monosex tilapia production.

18. Development of an effective biological nematicide, HeberNem, based on Tsukamurella paurometabola C924 strain.

19. Biopharming: use of plants as expression system for recombinant proteins.

20. Development of an E2 recombinant vaccine candidate against swine classical fever (SCF).

21. Vaccine candidate against rabbit hemorrhagic disease.

22. A yeast–based biocatalyzer for FOS production from sucrose.

23. Use of a growth stimulator, Acuabio 3, in ornamental fish species for growth and quality improvements of fish.

	CIGB
	Scientific pole
	Biomedical area
	Health impact
	New technologies
	Agriculture area
	Product registration
	Privacy policy
	Contacts
	Links
	Staff

Site best viewed at 1024 x 768 or greater resolution